Mouse models of Down syndrome

Drug Discovery Today: Disease Models

Volumn 2, Issue 2, 2005, Pages 103-109

  Davisson, Muriel T ^a  

^a JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BEHAVIOR DISORDER; CHROMOSOME 21; COGNITIVE DEFECT; COGNITIVE THERAPY; DISEASE MODEL; DISEASE SIMULATION; DOWN SYNDROME; GENE TARGETING; HUMAN; LIFESPAN; MOUSE STRAIN; NONHUMAN; PHENOTYPE; QUALITY OF LIFE; TRANSGENIC MOUSE; TRISOMY;

EID: 21844435217     PISSN: 17406757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmod.2005.05.007     Document Type: Review

References (40)

1. N.J. Roizen and D. Patterson Down's syndrome Lancet 361 2003 1281-1289
2. M.A. Abruzzo and T.J. Hassold Etiology of nondisjunction in humans Environ. Mol. Mutagen. 26 1995 38-47
3. D. Patterson and A.C.S. Costa Down syndrome and genetics - a case of linked histories Nat. Rev. Genet. 6 2005 137-147
4. M.T. Davisson et al. Evolutionary breakpoints on human chromosome 21 Genomics 78 2001 99-106
5. J.D. Gearhart et al. Autosomal aneuploidy in mice: Generation and developmental consequences Brain Res. Bull. 16 1986 789-801
6. M.L. Lacey-Casem and M.L. Oster-Granite The neuropathology of the trisomy 16 mouse Crit. Rev. Neurobiol. 8 1994 293-322
7. M. Ludwig et al. The embryonic development of sensory organs and the skull in the trisomy 16 mouse, an animal model for Down's syndrome Ann. Anat. 179 1997 525-533
8. T.N. Behar and C.A. Colton Redox regulation of neuronal migration in a Down syndrome model Free Radic. Biol. Med. 35 2003 566-575
9. Z. Galdzicki et al. Increased expression of voltage-activated calcium channels in cultured hippocampal neurons from mouse trisomy 16, a model for Down syndrome Brain Res. Mol. Brain Res. 56 1998 200-206
10. S. Peng et al. Abnormal chloride and potassium conductances in cultured embryonic tongue muscle from trisomy 16 mouse Brain Res. Dev. Brain Res. 122 2000 193-197
11. S. Webb et al. Endocardial cushion development and heart loop architecture in the trisomy 16 mouse Dev. Dyn. 206 1996 301-309
12. M.T. Davisson A.C.S. Costa Mouse models of Down syndrome. In Mouse Models of Human Genetic Neurological Disease (B. Popko, ed) 1999 Plenum Press
13. P. Kahlem et al. Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of Down syndrome Genome Res. 14 2004 1258-1267
14. E.C. Akeson et al. Ts65Dn - localization of the translocation breakpoint and trisomic gene content in a mouse model for Down syndrome Cytogenet. Cell Genet. 93 2001 270-276
15. L.S. Crnic and B.F. Pennington Down syndrome: Neuropsychology and animal models Prog. Infancy Res. 1 2000 69-111
16. R.H. Reeves et al. A mouse model for Down syndrome exhibits learning and behaviour deficits Nat. Genet. 11 1995 177-184
17. A.C. Costa et al. Motor dysfunction in a mouse model for Down syndrome Physiol. Behav. 68 1999 211-220
18. D.M. Holtzman et al. Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome Proc. Natl. Acad. Sci. USA 93 1996 13333-13338
19. A.C. Granholm et al. Estrogen restores cognition and cholinergic phenotype in an animal model of Down syndrome Physiol. Behav. 77 2002 371-378
20. G.R. Wenger et al. Operant conditioning in the Ts65Dn mouse: Learning Behav. Genet. 34 2004 105-119
21. M.E. Coussons-Read and L.S. Crnic Behavioral assessment of the Ts65Dn mouse, a model for Down syndrome: Altered behavior in the elevated plus maze and open field Behav. Genet. 26 1996 7-13
22. J.D. Cooper et al. Failed retrograde transport of NGF in a mouse model of Down's syndrome: Reversal of cholinergic neurodegenerative phenotypes following NGF infusion Proc. Natl. Acad. Sci. USA 98 2001 10439-10444
23. A. Salehi et al. Traffic at the intersection of neurotrophic factor signaling and neurodegeneration Trends Neurosci. 26 2003 73-80
24. P.V. Belichenko et al. Synaptic structural abnormalities in the Ts65Dn mouse model of Down syndrome J. Comp. Neurol. 480 2004 281-298
25. L.L. Baxter et al. Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse Hum. Mol. Genet. 9 2000 195-202
26. J.T. Richtsmeier et al. Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice Dev. Dyn. 217 2000 137-145
27. T.H. Moran et al. The effects of piracetam on cognitive performance in a mouse model of Down syndrome Physiol. Behav. 77 2002 403-409
28. H. Sago et al. Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities Proc. Natl. Acad. Sci. USA 95 1998 6256-6261
29. H. Sago et al. Genetic dissection of region associated with behavioral abnormalities in mouse models for Down syndrome Pediatr. Res. 48 2000 606-613
30. L.E. Olson et al. Down syndrome mouse models Ts65Dn, Ts1Cje, and Ms1Cje/ Ts65Dn exhibit variable severity of cerebellar phenotypes Dev. Dyn. 230 2004 581-589
31. J.T. Richtsmeier et al. Craniofacial phenotypes in segmentally trisomic mouse models for Down syndrome Am. J. Med. Genet. 107 2002 317-324
32. L.E. Olson et al. A chromosome 21 critical region does not cause specific Down syndrome phenotypes Science 306 2004 687-690
33. D. Hernandez et al. Transchromosomal mouse embryonic stem cell lines and chimeric mice that contain freely segregating segments of human chromosome 21 Hum. Mol. Genet. 8 1999 923-933
34. Y. Kazuki et al. A new mouse model for Down syndrome J. Neural. Transm. Suppl. 67 2003 1-20
35. I. Hanbauer et al. Evidence of increased oxidative stress in hippocampal primary cultures of trisomy 16 mouse. Studies on metallothionein-I/II Restor. Neurol. Neurosci. 12 1998 87-93
36. R.C. Klein et al. Kinetic and mechanistic characterization of NMDA receptor antagonism by replacement and truncation variants of the conantokin peptides Neuropharmacology 2001 801-810
37. R.J. Siarey et al. Increased synaptic depression in the Ts65Dn mouse, a model for mental retardation in Down syndrome Neuropharmacology 38 1999 1917-1920
38. F. Tassone et al. Gene expression relevant to Down syndrome: Problems and approaches J. Neural Transm. Suppl. 57 1999 179-195
39. J.W. Taub et al. Enhanced metabolism of 1-beta-d-arabinofuranosylcytosine in Down syndrome cells: A contributing factor to the superior event free survival of Down syndrome children with acute myeloid leukemia Blood 87 1996 3395-3403
40. K. Gardiner et al. Building protein interaction maps for Down syndrome Brief. Funct. Genomics Proteomics 3 2004 142-156